EUCTR2011-001370-26-Outside-EU/EEA进行中（未招募）不适用
Randomized, Double-Blind Trial of MP29-02 Nasal Spray Compared to Placebo, Azelastine Hydrochloride Nasal Spray, and Fluticasone Propionate Nasal Spray in the Treatment of Patients with Seasonal Allergic Rhinitis
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 780
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with moderate-to-severe rhinitis
- •12-hour reflective Total Nasal Symptom Score (TNSS) of at least 8 out of a possible 12 on screening visit, and a congestion score of 2 or 3 on visit 1
- •12-hour reflective TNSS of at least 8 on 3 separate symptom assessments during the lead-in period
- •12-hour reflective nasal congestion score of 2 or 3 recorded on 3 separate symptom assessments during the lead-in period
- •Instantaneous TNSS of 8 or more at time point zero
- •At least 2-year history of SAR during fall allergy season
- •Presence of IgE-mediated hypersensitivity to a local fall pollen, confirmed by a positive response to skin prick within the last year
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 55
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 707
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 14
排除标准
- •Presence on nasal examination of any superficial and moderate mucosal erosion, nasal ulceration, or nasal septal perforation on screening visit or randomisation visit
- •Nasal surgery or sinus surgery within the previous year
- •Chronic sinusitis with more than 3 episodes per year
- •Patients currently or during the previous 6-months on sublingual immunotherapy
- •Female adolescents who were pregnant or nursing
- •Patients receiving immunotherapy injections and not on stable maintenance regimen for at least 30 days before the first study visit
研究者
相似试验
进行中（未招募）
不适用
Study comparing the effect of a nasal spray combination of azelastine and fluticasone with azelastine nasal spray, fluticasone nasal spray anda nasal spray without active substance in the treatment of patients with hay feverEUCTR2011-001371-39-Outside-EU/EEAMeda Pharmaceuticals Inc.1,800
进行中（未招募）
不适用
Study comparing the effect of a nasal spray combination of azelastine and fluticasone with azelastine nasal spray, fluticasone nasal spray anda nasal spray without active substance in the treatment of patients with hay fevertreatment of seasonal allergic rhinitisMedDRA version: 13.1Level: LLTClassification code 10039776Term: Seasonal allergic rhinitisSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2011-001369-42-Outside-EU/EEAMeda Pharmaceuticals Inc.780
进行中（未招募）
不适用
Study comparing the effect of a nasal spray combination of azelastine and fluticasone with azelastine nasal spray, fluticasone nasal spray and a nasal spray without active substance in the treatment of patients with hay feverEUCTR2011-001314-34-Outside-EU/EEAMedPointe Pharmaceuticals600
进行中（未招募）
不适用
Treatment with Iloprost and Integrilin compared to standard care in severe pneumonia patients with severe sepsis.EUCTR2011-002254-31-FIRigshospitalet, ITA 4131, Department of Intensive care36
进行中（未招募）
1 期
Treatment with Iloprost and Integrilin compared to standard care in severe pneumonia patients with severe sepsis.EUCTR2011-002254-31-DKRigshospitalet, ITA 4131, Department of Intensive care36